1. Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes
- Author
-
Eduful, BJ, O'Byrne, SN, Temme, L, Asquith, CRM, Liang, Y, Picado, A, Pilotte, JR, Hossain, MA, Wells, C, Zuercher, WJ, Catta-Preta, CMC, Ramos, PZ, Santiago, ADS, Counago, RM, Langendorf, CG, Nay, K, Oakhill, JS, Pulliam, TL, Lin, C, Awad, D, Willson, TM, Frigo, DE, Scott, JW, Drewry, DH, Eduful, BJ, O'Byrne, SN, Temme, L, Asquith, CRM, Liang, Y, Picado, A, Pilotte, JR, Hossain, MA, Wells, C, Zuercher, WJ, Catta-Preta, CMC, Ramos, PZ, Santiago, ADS, Counago, RM, Langendorf, CG, Nay, K, Oakhill, JS, Pulliam, TL, Lin, C, Awad, D, Willson, TM, Frigo, DE, Scott, JW, and Drewry, DH
- Abstract
CAMKK2 is a serine/threonine kinase and an activator of AMPK whose dysregulation is linked with multiple diseases. Unfortunately, STO-609, the tool inhibitor commonly used to probe CAMKK2 signaling, has limitations. To identify promising scaffolds as starting points for the development of high-quality CAMKK2 chemical probes, we utilized a hinge-binding scaffold hopping strategy to design new CAMKK2 inhibitors. Starting from the potent but promiscuous disubstituted 7-azaindole GSK650934, a total of 32 compounds, composed of single-ring, 5,6-, and 6,6-fused heteroaromatic cores, were synthesized. The compound set was specifically designed to probe interactions with the kinase hinge-binding residues. Compared to GSK650394 and STO-609, 13 compounds displayed similar or better CAMKK2 inhibitory potency in vitro, while compounds 13g and 45 had improved selectivity for CAMKK2 across the kinome. Our systematic survey of hinge-binding chemotypes identified several potent and selective inhibitors of CAMKK2 to serve as starting points for medicinal chemistry programs.
- Published
- 2021